Congenital hyperinsulinism in a newborn presenting with poor feeding

Kiran Mazloom1, Pedro A Sanchez-Lara2, Seth Langston3

  • 1College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA, USA.

Insights

Congenital hyperinsulinism causes persistent hypoglycemia in infants, potentially leading to severe brain injury. A novel genetic variant was identified in a unique case, underscoring early diagnosis importance.

Area of Science:

  • Endocrinology
  • Genetics
  • Pediatrics

Background:

  • Hyperinsulinemic hypoglycemia involves dysregulated insulin secretion, posing risks to infant brain development.
  • Persistent hypoglycemia and hypoketosis in infants can lead to severe neurological damage like epilepsy and cerebral palsy.
  • Congenital hyperinsulinism is the primary cause of persistent hypoglycemia in neonates and children.

Observation:

  • A case study details an infant with a unique presentation of hyperinsulinism.
  • This infant was found to have a novel genetic variant responsible for the condition.
  • The presentation involved poor feeding in the newborn period.

Findings:

  • A novel genetic variant was identified as the cause of congenital hyperinsulinism in the presented case.
  • This finding expands the known genetic causes of hyperinsulinism.
  • The case highlights a unique clinical presentation.

Implications:

  • Early recognition and treatment of congenital hyperinsulinism are crucial to prevent neurological sequelae.
  • A broad differential diagnosis, including congenital hyperinsulinism, is important for infants with poor feeding.
  • Identifying novel genetic variants aids in understanding the pathophysiology and improving diagnostic approaches for hyperinsulinism.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
292
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.4K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
363
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
25.2K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.4K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K